Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 2 (2005), Issue 7 (July)

1. Effect of presentation modality on immediate and delayed recall in individuals with Alzheimer's disease.
   Am J Speech Lang Pathol, 14(2): 144-55. [Abstract] [Full-text]
2. Dynein mutations impair autophagic clearance of aggregate-prone proteins.
   Nat Genet, 37(7): 771-6. [Abstract] [Full-text]
3. Sustained attention in mild Alzheimer's disease.
   Dev Neuropsychol, 28(1): 507-37. [Abstract] [Full-text]
4. Factors associated with self- and caregiver report of pain among community-dwelling persons with dementia.
   J Palliat Med, 8(3): 567-75. [Abstract] [Full-text]
5. A 10-item smell identification scale related to risk for Alzheimer's disease.
   Ann Neurol, 58(1): 155-60. [Abstract] [Full-text]
6. Brain activation in offspring of AD cases corresponds to 10q linkage.
   Ann Neurol, 58(1): 142-6. [Abstract] [Full-text]
7. Amyloid beta 38, 40, and 42 species in cerebrospinal fluid: more of the same?
   Ann Neurol, 58(1): 139-42. [Abstract] [Full-text]
8. Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease.
   Brain Res, 1050(1): 210-6. [Abstract] [Full-text]
9. Visual attention deficits in Alzheimer's disease: an fMRI study.
   Neurosci Lett, 385(1): 18-23. [Abstract] [Full-text]
10. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.
    Psychiatry Res, 139(2): 79-88. [Abstract] [Full-text]
11. Tc-99m HMPAO brain SPECT findings in mild and moderate Alzheimer's disease: correlation with event related potentials.
    J Neurol Sci, 234(1): 47-53. [Abstract] [Full-text]
12. Aberrant accentuation of neurofibrillary degeneration in the hippocampus of Alzheimer's disease with amyloid precursor protein 717 and presenilin-1 gene mutations.
    J Neurol Sci, 234(1): 55-65. [Abstract] [Full-text]
13. Post-stroke dementia is associated with alpha(1)-antichymotrypsin polymorphism.
    J Neurol Sci, 234(1): 31-6. [Abstract] [Full-text]
14. N-methyl-D-aspartate receptor and apoptosis in Alzheimer's disease and multiinfarct dementia.
    J Neurosci Res, 81(2): 269-74. [Abstract] [Full-text]
15. The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.
    J Biol Chem, 280(27): 25754-9. [Abstract] [Full-text]
16. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Virus Res, 111(2): 194-213. [Abstract] [Full-text]
17. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
    Arch Gen Psychiatry, 62(7): 726-33. [Abstract] [Full-text]
18. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
    Neuron, 47(1): 29-41. [Abstract] [Full-text]
19. The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.
    Neuron, 47(1): 1-3. [Abstract] [Full-text]
20. Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 69-71. [Abstract] [Full-text]
21. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Am J Med Genet B Neuropsychiatr Genet, 136(1): 62-8. [Abstract] [Full-text]
22. Sexually inappropriate behaviour in demented elderly people.
    Postgrad Med J, 81(957): 463-6. [Abstract] [Full-text]
23. Reinstatement of conditioned fear in humans is context dependent and impaired in amnesia.
    Behav Neurosci, 119(3): 677-86. [Abstract] [Full-text]
24. Lucidity in a woman with severe dementia related to conversation. a case study.
    J Clin Nurs, 14(7): 891-6. [Abstract] [Full-text]
25. Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease.
    Neurocase, 11(3): 216-26. [Abstract] [Full-text]
26. Can 'football-team color-code' compensate for anomia? The case study of FN, a patient with color anomia.
    Neurocase, 11(3): 227-33. [Abstract] [Full-text]
27. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology.
    Neurocase, 11(3): 204-11. [Abstract] [Full-text]
28. Is slowly progressive anarthria a "pure" motor-speech disorder? Evidence from writing performance.
    Neurocase, 11(3): 234-41. [Abstract] [Full-text]
29. Prevalence of dementia in the elderly in Europe.
    Eur Neuropsychopharmacol, 15(4): 463-71. [Abstract] [Full-text]
30. Neuropsychological functioning of dementia patients with psychosis.
    Arch Clin Neuropsychol, 20(6): 771-83. [Abstract] [Full-text]
31. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Med Hypotheses, 65(3): 498-500. [Abstract] [Full-text]
32. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes.
    Arch Neurol, 62(7): 1106-10. [Abstract] [Full-text]
33. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration.
    Arch Neurol, 62(7): 1097-101. [Abstract] [Full-text]
34. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
    Arch Neurol, 62(7): 1047-51. [Abstract] [Full-text]
35. Impaired recognition of negative facial emotions in patients with frontotemporal dementia.
    Neuropsychologia, 43(11): 1673-87. [Abstract] [Full-text]
36. Patients with mild Alzheimer's disease attribute conceptual fluency to prior experience.
    Neuropsychologia, 43(11): 1662-72. [Abstract] [Full-text]
37. Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus.
    Neuropathol Appl Neurobiol, 31(4): 395-404. [Abstract] [Full-text]
38. A new family with frontotemporal dementia with intronic 10+3 splice site mutation in the tau gene: neuropathology and molecular effects.
    Neuropathol Appl Neurobiol, 31(4): 362-73. [Abstract] [Full-text]
39. From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy.
    Acta Neurol Scand, 112(2): 65-71. [Abstract] [Full-text]
40. Bovine spongiform encephalopathy, multiple sclerosis, and creutzfeldt-jakob disease are probably autoimmune diseases evoked by Acinetobacter bacteria.
    Ann N Y Acad Sci, 1050: 417-28. [Abstract] [Full-text]
41. Predictive genetic test decisions for Huntington's disease: elucidating the test/no-test dichotomy.
    J Health Psychol, 10(4): 597-612. [Abstract] [Full-text]
42. Order and disorder in conversation: encounters with dementia of the Alzheimer's type.
    Clin Linguist Phon, 19(5): 393-404. [Abstract] [Full-text]
43. Mayo's Older African American Normative Studies: norms for the Mattis Dementia Rating Scale.
    Clin Neuropsychol, 19(2): 229-42. [Abstract] [Full-text]
44. Making sense of dementia and adjusting to loss: psychological reactions to a diagnosis of dementia in couples.
    Aging Ment Health, 9(4): 337-47. [Abstract] [Full-text]
45. Depressive disorders in caregivers of dementia patients: a systematic review.
    Aging Ment Health, 9(4): 325-30. [Abstract] [Full-text]
46. Immersion autometallographic tracing of zinc ions in Alzheimer beta-amyloid plaques.
    Histochem Cell Biol, 123(6): 605-11. [Abstract] [Full-text]
47. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
    Pharmacopsychiatry, 38(4): 183-4. [Abstract] [Full-text]
48. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
    Pharmacopsychiatry, 38(4): 178-9. [Abstract] [Full-text]
49. Is dementia reversible in patients with neurocysticercosis?
    J Neurol Neurosurg Psychiatry, 76(8): 1164-6. [Abstract] [Full-text]
50. On the overlap between apathy and depression in dementia.
    J Neurol Neurosurg Psychiatry, 76(8): 1070-4. [Abstract] [Full-text]
51. Neurophysiological predictors of long term response to AChE inhibitors in AD patients.
    J Neurol Neurosurg Psychiatry, 76(8): 1064-9. [Abstract] [Full-text]
52. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
    J Neurol Neurosurg Psychiatry, 76(8): 1058-63. [Abstract] [Full-text]
53. Follow-up of an intervention program for caregivers of a relative with dementia living in a long-term care setting: Are there any persistent and delayed effects?
    Aging Ment Health, 9(5): 461-9. [Abstract] [Full-text]
54. GP attitudes to early diagnosis of dementia: evidence of improvement.
    Aging Ment Health, 9(5): 449-55. [Abstract] [Full-text]
55. Improving website accessibility for people with early-stage dementia: a preliminary investigation.
    Aging Ment Health, 9(5): 442-8. [Abstract] [Full-text]
56. Experiences in early stage Alzheimer's disease: understanding the paradox of acceptance and denial.
    Aging Ment Health, 9(5): 430-41. [Abstract] [Full-text]
57. Awareness in dementia: ethical and legal issues in relation to people with dementia.
    Aging Ment Health, 9(5): 423-9. [Abstract] [Full-text]
58. Awareness in dementia: a review of clinical correlates.
    Aging Ment Health, 9(5): 414-22. [Abstract] [Full-text]
59. Awareness in dementia: A review of assessment methods and measures.
    Aging Ment Health, 9(5): 394-413. [Abstract] [Full-text]
60. Awareness in dementia: conceptual issues.
    Aging Ment Health, 9(5): 386-93. [Abstract] [Full-text]
61. The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: intracellular redistribution of components correlates with neuronal vulnerability.
    Neurobiol Dis, 19(3): 427-35. [Abstract] [Full-text]
62. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Clin Neurol Neurosurg, 107(5): 396-403. [Abstract] [Full-text]
63. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Clin Neurol Neurosurg, 107(5): 355-60. [Abstract] [Full-text]
64. Amyloid-beta fibril formation is not necessarily required for microglial activation by the peptides.
    Neurochem Int, 47(5): 369-76. [Abstract] [Full-text]
65. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Eur J Cancer, 41(11): 1588-96. [Abstract] [Full-text]
66. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
    Exp Brain Res, 164(2): 205-14. [Abstract] [Full-text]
67. Studying individual aging in an interindividual context: typical paths of age-related, dementia-related, and mortality-related cognitive development in old age.
    Psychol Aging, 20(2): 303-16. [Abstract] [Full-text]
68. Possible selves of individuals with Alzheimer's disease.
    Psychol Aging, 20(2): 285-94. [Abstract] [Full-text]
69. Transitions in caregivers' use of paid home help: associations with stress appraisals and well-being.
    Psychol Aging, 20(2): 211-9. [Abstract] [Full-text]
70. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients.
    Brain, 128: 1790-801. [Abstract] [Full-text]
71. LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.
    Brain, 128: 1778-89. [Abstract] [Full-text]
72. The age-dependent relation of blood pressure to cognitive function and dementia.
    Lancet Neurol, 4(8): 487-99. [Abstract] [Full-text]
73. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington's disease mutation.
    J Neurochem, 94(3): 639-50. [Abstract] [Full-text]
74. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease.
    Ann N Y Acad Sci, 1043: 211-6. [Abstract] [Full-text]
75. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.
    J Neurovirol, 11(3): 265-73. [Abstract] [Full-text]
76. Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.
    Exp Aging Res, 31(3): 345-54. [Abstract] [Full-text]
77. Long-term effectiveness of spaced-retrieval memory training for older adults with probable Alzheimer's disease.
    Exp Aging Res, 31(3): 261-89. [Abstract] [Full-text]
78. Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease.
    Biochem Biophys Res Commun, 334(2): 342-8. [Abstract] [Full-text]
79. Underlying cause of death in demented and non-demented elderly Canadians.
    Neuroepidemiology, 25(2): 75-84. [Abstract] [Full-text]
80. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
    Parkinsonism Relat Disord, 11(5): 311-5. [Abstract] [Full-text]
81. Relationship between Parkinson disease with dementia and dementia with Lewy bodies.
    Parkinsonism Relat Disord, 11(5): 305-9. [Abstract] [Full-text]
82. Magnetic resonance imaging findings in pre-clinical Creutzfeldt-Jakob disease.
    Int J Neurosci, 115(8): 1219-25. [Abstract] [Full-text]
83. Neuropsychological measures and single photon emission computed tomography in the differentiation and classification of cerebral perfusion deficits in Alzheimer's dementia.
    Int J Neurosci, 115(8): 1131-49. [Abstract] [Full-text]
84. The bad seed in Alzheimer's disease.
    Neuron, 47(2): 167-8. [Abstract] [Full-text]
85. Novel method to estimate and display cerebral cortical degeneration using diffusion-weighted magnetic resonance imaging.
    Magn Reson Med, 54(2): 455-9. [Abstract] [Full-text]
86. Increased glutathione levels in cortical and striatal mitochondria of the R6/2 Huntington's disease mouse model.
    Neurosci Lett, 386(1): 63-8. [Abstract] [Full-text]
87. The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype.
    Microb Pathog, 39(1): 19-26. [Abstract] [Full-text]
88. Frontotemporal dementia, motor neuron disease and tauopathy: clinical and neuropathological study in a family.
    Acta Neuropathol (Berl), 110(1): 84-92. [Abstract] [Full-text]
89. The Alzheimer beta-peptide shows temperature-dependent transitions between left-handed 3-helix, beta-strand and random coil secondary structures.
    FEBS J, 272(15): 3938-49. [Abstract] [Full-text]
90. Stress proteins in Alzheimer's disease.
    Int J Hyperthermia, 21(5): 421-31. [Abstract] [Full-text]
91. Depression and associated factors of informal caregivers versus professional caregivers of demented patients.
    Psychiatry Clin Neurosci, 59(4): 473-80. [Abstract] [Full-text]
92. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
    Nat Genet, 37(8): 806-8. [Abstract] [Full-text]
93. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia.
    J Virol, 79(16): 10830-4. [Abstract] [Full-text]
94. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study.
    Int J Neurosci, 115(7): 965-80. [Abstract] [Full-text]
95. Analysis of regularity in the EEG background activity of Alzheimer's disease patients with Approximate Entropy.
    Clin Neurophysiol, 116(8): 1826-34. [Abstract] [Full-text]
96. CAT 53: a protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer's disease.
    Brain Res Mol Brain Res, 138(1): 70-83. [Abstract] [Full-text]

© 2004-2008 Dementia Research Today. All Rights Reserved.